Del Aversano Robert J Insider Trades

Insider Trading History

Track insider trading activity for Del Aversano Robert J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
OncoSec Medical
OncoSec Medical ONCS
Principal Accounting Officer
Holding Value $7.05k 25,433 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 8,750 shares
$168.08
$0.28
OncoSec Medical
OncoSec Medical ONCS
Principal Accounting Officer
Holding Value $7.48k 27,000 shares
Last Trade
Aug 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 27,000 shares
$84.04
$0.28
OncoSec Medical
OncoSec Medical ONCS
Principal Accounting Officer
Holding Value $7.03k 25,362 shares
Last Trade
May 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 25,362 shares
$49.06
$0.28
OncoSec Medical
OncoSec Medical ONCS
Principal Accounting Officer
Holding Value $15k 54,054 shares
Last Trade
May 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.65M 54,054 shares
$49.06
$0.28
OncoSec Medical
OncoSec Medical ONCS
Principal Accounting Officer
Holding Value $4.62k 16,683 shares
Last Trade
May 29, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$426k 8,679 shares
$49.06
$0.28
U.S. Gold
U.S. Gold USAU
See Remarks
Holding Value $0 0 shares
Last Trade
Apr 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$745k 50,000 shares
$14.90
$15.67

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up